Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don Chamith Halahakoon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Topics in Behavioral Neurosciences|November 20, 2023
Pramipexole for the Treatment of Depression: Efficacy and MechanismsDon Chamith Halahakoon, Michael Browning
The International Journal of Neuropsychopharmacology|May 23, 2022
Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy VolunteersAlexander Kaltenboeck, Don Chamith Halahakoon, Catherine J Harmer, et al.
Psychopharmacology|March 18, 2024
The effects of pramipexole on motivational vigour during a saccade task: a placebo-controlled study in healthy adultsSheena K Au-Yeung, Don Chamith Halahakoon, Alexander Kaltenboeck, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy VolunteersMarieke Annie Gerdine Martens, Alexander Kaltenboeck, Don Chamith Halahakoon, et al.
Biological Psychiatry|June 17, 2023
Pramipexole Enhances Reward Learning by Preserving Value EstimatesDon Chamith Halahakoon, Alexander Kaltenboeck, Marieke Martens, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
A computational approach to understanding effort-based decision-making in depressionVincent Valton, Anahit Mkrtchian, Madeleine Moses-Payne, et al.
Psychological Medicine|October 8, 2025
A computational approach to understanding effort-based decision-making in depressionVincent Valton, Anahit Mkrtchian, Madeleine Moses-Payne, et al.
The Lancet. Psychiatry|July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UKMichael Browning, Philip J Cowen, Ushma Galal, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Topics in Behavioral Neurosciences|November 20, 2023
Pramipexole for the Treatment of Depression: Efficacy and MechanismsDon Chamith Halahakoon, Michael Browning
The International Journal of Neuropsychopharmacology|May 23, 2022
Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy VolunteersAlexander Kaltenboeck, Don Chamith Halahakoon, Catherine J Harmer, et al.
Psychopharmacology|March 18, 2024
The effects of pramipexole on motivational vigour during a saccade task: a placebo-controlled study in healthy adultsSheena K Au-Yeung, Don Chamith Halahakoon, Alexander Kaltenboeck, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy VolunteersMarieke Annie Gerdine Martens, Alexander Kaltenboeck, Don Chamith Halahakoon, et al.
Biological Psychiatry|June 17, 2023
Pramipexole Enhances Reward Learning by Preserving Value EstimatesDon Chamith Halahakoon, Alexander Kaltenboeck, Marieke Martens, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
A computational approach to understanding effort-based decision-making in depressionVincent Valton, Anahit Mkrtchian, Madeleine Moses-Payne, et al.
Psychological Medicine|October 8, 2025
A computational approach to understanding effort-based decision-making in depressionVincent Valton, Anahit Mkrtchian, Madeleine Moses-Payne, et al.
The Lancet. Psychiatry|July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UKMichael Browning, Philip J Cowen, Ushma Galal, et al.
Pageof 1